← All In8bio, INC filings

In8bio, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
INAB
In8bio, INC
10-K/A: IN8bio Files Amendment No. 1 to Form 10-K to Correct Exhibit List and Include Updated Certifications
IN8bio, Inc. files an amendment to its annual report on Form 10-K to correct the exhibit list and include new certifications from its principal executive and financial officers.
NASDAQ
INAB
In8bio, INC
10-K: IN8bio Reports Promising Data in AML Trial, Prioritizes Pipeline Amidst Financial Constraints
IN8bio's 10-K filing reveals encouraging clinical trial results for INB-100 in AML patients, a pipeline prioritization strategy, and efforts to secure additional funding amidst going concern uncertainties.
NASDAQ
INAB
In8bio, INC
10-K: IN8bio Details Capital Structure, Warrants, and Anti-Takeover Measures in 10-K Filing
IN8bio's 10-K filing outlines its capital structure, including common and preferred stock, warrants issued in a recent private placement, and various anti-takeover provisions.